Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.

Clinical trial NCT07448116 · RECRUITING

Trial details

NCT number: NCT07448116
Sponsor: Betta Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Advanced Tumor

Start date: 2026-01-31
Primary completion: 2029-02-01
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.